𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivastigmine treatment in Parkinson's disease dementia: Short-term cholinergic effects are correlated with six-month treatment response

✍ Scribed by Adler, Georg; Christenn, Michaela; Bektas, Miriam; Ko-Inoshishi, Youko; Kupsch, Andreas; Scholz, Erich; Articus, Konstantin

Book ID
122859846
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
107 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term benefits of rivastigmine in de
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
✍ Werner Poewe; Erik Wolters; Murat Emre; Marco Onofrj; Chuanchieh Hsu; Sibel Teki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract In patients with dementia associated with Parkinson's disease (PD), the efficacy and safety of rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, were previously demonstrated in a 24‐week double‐blind placebo‐controlled trial. Our objective was to determine wh